News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Kohei Shitara: LEAP15 for gastric cancer did not meet OS endpoint
Kohei Shitara/X
Jan 27, 2025, 09:40

Kohei Shitara: LEAP15 for gastric cancer did not meet OS endpoint

Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared a post on X:

“LEAP15 for gastric cancer did not meet OS endpoint. Drop of chemo or dose of LEN/toxicities matter? Need learn from negative trial.”

Read further.

More posts featuring Kohei Shitara.

cancer Kohei shitara LEAP15 OncoDaily Oncology
Special Coverage
Insight
Jan 27, 2025, 09:40
Kohei Shitara: LEAP15 for gastric cancer did not meet OS endpoint
Blog
Jan 27, 2025, 09:39
Mohamedtaki A. Tejani: A crash course on Bayesian design at ASCOGI25
Blog
Jan 27, 2025, 09:39
Shivani Modi: Amazing discussion on how supportive oncology will help patients at ASCO GI 2025
Blog
Jan 27, 2025, 09:36
Cathy Eng: ECOG PS in identifying pancreatic cancer patients for chemotherapy
Blog
Jan 27, 2025, 09:34
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer
Blog
Jan 27, 2025, 09:32
Discussing research collaborations with Egypt's Presidential Initiative for Women's Health at BGICC - IARC/WHO
Blog
Jan 27, 2025, 09:30
Khalid El Bairi: It was a true pleasure to present at OncoVision2025
Blog
Jan 27, 2025, 09:28
Pashtoon Kasi: The science moves fast, but the people make it special
Blog
Jan 27, 2025, 09:28
Nadia Bordoli: AIRC - Foundation for Cancer Research NGO celebrates sixty years of commitment to making cancer increasingly curable
Blog
Jan 27, 2025, 09:27
Douglas Flora: I always say that fighting cancer care is a team sport
Blog
Jan 27, 2025, 09:24
Daniel Portik shares his experience at the MCCR Workshop - EORTC
Blog
Jan 27, 2025, 09:24
Bernard A. Fox: UbiVac is excited to have the world’s 1st immunotherapy that targets cancer’s Dark Matter